{"database": "openregs", "table": "federal_register", "rows": [["2012-22195", "Withdrawal of Approval of New Animal Drug Applications; Chorionic Gonadotropin; Naloxone; Oxymorphone; Oxytocin", "Notice", "The Food and Drug Administration (FDA) is withdrawing approval of four new animal drug applications (NADAs) at the sponsor's request because the products are no longer manufactured or marketed.", "2012-09-10", 2012, 9, "https://www.federalregister.gov/documents/2012/09/10/2012-22195/withdrawal-of-approval-of-new-animal-drug-applications-chorionic-gonadotropin-naloxone-oxymorphone", "https://www.govinfo.gov/content/pkg/FR-2012-09-10/pdf/2012-22195.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is withdrawing approval of four new animal drug applications (NADAs) at the sponsor's request because the products are no longer manufactured or marketed.", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2012-22195"], "units": {}, "query_ms": 0.31084800139069557, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}